The community speaks

Every year, our program includes keynote speeches by some of the top thinkers and trend-makers in pharma, biotech, medtech, digital health, investment & funding, regulatory.

NLSDays features company presentations organised into tracks that interest specific audiences and fields, for example: pharma and biotechnology in R&D, therapeutics or diagnostics, academic and startup innovators, services providers.

Super Sessions address hot topics in science, business development and market strategies.

In between all of these delightful speaking events, we make sure everyone is refreshed by a classic Swedish ‘fika’ – all that your heart desires, plus lots of coffee.

Ms. Sana Alajmovic

Co-Founder & CEO, Sigrid Therapeutics

28 Sep 09:15 Plenary Room NLSDays Grand Opening

Dr. Andrea Ballagi

VP Sales and Marketing, Olink Proteomics

29 Sep 08:30 Plenary Room Super Session 4 – A Multi-omics Approach to Disease

Ms. Maria Bech

CEO, EpiEndo Pharmaceuticals

28 Sep 09:15 Plenary Room NLSDays Grand Opening

Dr. Karin Conde-Knape

Senior Vice President Global Drug Discovery, Novo Nordisk

28 Sep 09:15 Plenary Room NLSDays Grand Opening

Dr. Matthias Degroote

Applied Quantum Computing Scientist, Boehringer Ingelheim

28 Sep 11:00 Plenary Room Super Session 1 – Diving into Deep Tech – From Buzzword to Benefit in Life Sciences

Mr. Olivier Duchamp

Managing Director, NLSDays - VP International BD & Promotion, SwedenBIO

28 Sep 09:15 Plenary Room NLSDays Grand Opening

Ms. Anya Eldan

CEO, Nury Ventures

28 Sep 14:00 Plenary Room Super Session 2 – Vertical Life Science – How Convergence is Erasing Silos

Mr. Michael Engsig

CEO, Nykode Therapeutics

28 Sep 09:15 Plenary Room NLSDays Grand Opening

28 Sep 16:00 Plenary Room Super Session 3 – Vaccine Crosslinks: From Cancer to COVID

Dr. Armend G. Håti

CEO & Co-founder, ClexBio

28 Sep 11:00 Plenary Room Super Session 1 – Diving into Deep Tech – From Buzzword to Benefit in Life Sciences

Dr. Gunnveig Grødeland

Senior Scientist and Research Group Leader, University of Oslo

28 Sep 16:00 Plenary Room Super Session 3 – Vaccine Crosslinks: From Cancer to COVID

Dr. Christian Grøndahl

Co-founder & CEO, SNIPR BIOME

28 Sep 09:15 Plenary Room NLSDays Grand Opening

Ms. Kaisa Helminen

Chief Operating Officer, Aiforia Technologies

28 Sep 11:00 Plenary Room Super Session 1 – Diving into Deep Tech – From Buzzword to Benefit in Life Sciences

Dr. Carl Kilander

Partner, HealthCap

28 Sep 16:00 Plenary Room Super Session 3 – Vaccine Crosslinks: From Cancer to COVID

Dr. Holger Kissel

Vice President Business Alliances, BioNTech SE

28 Sep 16:00 Plenary Room Super Session 3 – Vaccine Crosslinks: From Cancer to COVID

Prof. Emma Lundberg

Founder & Chairman, MindForce GameLab

28 Sep 14:00 Plenary Room Super Session 2 – Vertical Life Science – How Convergence is Erasing Silos

Ms. Anne Margrethe M. Platou

ESG Analyst, DNB Markets

29 Sep 14:00 Plenary Room Super Session 6 – Follow the Money – Investors Leading the Way to Sustainability

Ms. Eleanor Malone

Editor in Chief, Pharma intelligence

28 Sep 16:00 Plenary Room Super Session 3 – Vaccine Crosslinks: From Cancer to COVID

Ms. Alice Mattsson

Founder, Pharmista Technologies

29 Sep 14:00 Plenary Room Super Session 6 – Follow the Money – Investors Leading the Way to Sustainability

Dr. Lisa Melton

Senior News Editor, Nature Biotechnology

29 Sep 08:30 Plenary Room Super Session 4 – A Multi-omics Approach to Disease

Ms. Maarit Merla

Head of Business Development, Forendo Pharma

Dr. Kelle Moley

Deputy Director of Reproductive Health Technologies, Global Health, Bill & Melinda Gates Foundation

29 Sep 11:00 Plenary Room Super Session 5 – Gender Science: Reproducing for the Other 50%

Dr. Victor Neduva

Senior Director Discovery Research, MSD

29 Sep 08:30 Plenary Room Super Session 4 – A Multi-omics Approach to Disease

Dr. Anders Persson

Executive Director Ecosystem Strategy & Innovation, AstraZeneca

28 Sep 14:00 Plenary Room Super Session 2 – Vertical Life Science – How Convergence is Erasing Silos

Ms. Chelsea Ranger

Chair of NLSInvest Committee & Senior Advisor, SwedenBIO

29 Sep 11:00 Plenary Room Super Session 5 – Gender Science: Reproducing for the Other 50%

Dr. João Ribas

Senior Associate, Novo Holdings

28 Sep 14:00 Plenary Room Super Session 2 – Vertical Life Science – How Convergence is Erasing Silos

Mr. Mike Ryan

Executive Vice President Europe, Eversana

28 Sep 16:00 Plenary Room Super Session 3 – Vaccine Crosslinks: From Cancer to COVID

Mr. Prateek Singh

CEO, Finnadvance

28 Sep 09:15 Plenary Room NLSDays Grand Opening

Dr. David Sonnek

CEO, Navigare Ventures

28 Sep 11:00 Plenary Room Super Session 1 – Diving into Deep Tech – From Buzzword to Benefit in Life Sciences

Prof. Kári Stefánsson

Founder & CEO, deCODE genetics

29 Sep 08:30 Plenary Room Super Session 4 – A Multi-omics Approach to Disease

Dr. Richard Stratford

CEO & Co-founder, OncoImmunity

28 Sep 16:00 Plenary Room Super Session 3 – Vaccine Crosslinks: From Cancer to COVID

Ms. Helena Strigård

CEO, SwedenBIO

28 Sep 09:15 Plenary Room NLSDays Grand Opening

Ms. Masha Strømme

Co-Chair, PAACS Invest

29 Sep 11:00 Plenary Room Super Session 5 – Gender Science: Reproducing for the Other 50%

Dr. Christina Östberg Lloyd

Lead Reproductive Medicine and Maternal Health, Ferring Pharmaceuticals

29 Sep 11:00 Plenary Room Super Session 5 – Gender Science: Reproducing for the Other 50%

View profile

Dr. Christina Östberg Lloyd

Lead Reproductive Medicine and Maternal Health, Ferring Pharmaceuticals

Lean

Prof. Margrét Þorsteinsdóttir

Professor Pharmaceutical Sciences, University of Iceland

29 Sep 08:30 Plenary Room Super Session 4 – A Multi-omics Approach to Disease